[go: up one dir, main page]

GB2110086A - Subcutaneous implant - Google Patents

Subcutaneous implant Download PDF

Info

Publication number
GB2110086A
GB2110086A GB08232140A GB8232140A GB2110086A GB 2110086 A GB2110086 A GB 2110086A GB 08232140 A GB08232140 A GB 08232140A GB 8232140 A GB8232140 A GB 8232140A GB 2110086 A GB2110086 A GB 2110086A
Authority
GB
United Kingdom
Prior art keywords
animal
glass
trace elements
subcutaneous implant
implant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB08232140A
Other versions
GB2110086B (en
Inventor
Cyril Francis Drake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STC PLC
Original Assignee
Standard Telephone and Cables PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB7838222A external-priority patent/GB2030559B/en
Application filed by Standard Telephone and Cables PLC filed Critical Standard Telephone and Cables PLC
Priority to GB08232140A priority Critical patent/GB2110086B/en
Publication of GB2110086A publication Critical patent/GB2110086A/en
Application granted granted Critical
Publication of GB2110086B publication Critical patent/GB2110086B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K13/00Devices for grooming or caring of animals, e.g. curry-combs; Fetlock rings; Tail-holders; Devices for preventing crib-biting; Washing devices; Protection against weather conditions or insects
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K29/00Other apparatus for animal husbandry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61DVETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/022Artificial gland structures using bioreactors
    • CCHEMISTRY; METALLURGY
    • C03GLASS; MINERAL OR SLAG WOOL
    • C03CCHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C3/00Glass compositions
    • C03C3/12Silica-free oxide glass compositions
    • CCHEMISTRY; METALLURGY
    • C03GLASS; MINERAL OR SLAG WOOL
    • C03CCHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C4/00Compositions for glass with special properties
    • C03C4/0035Compositions for glass with special properties for soluble glass for controlled release of a compound incorporated in said glass

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Environmental Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)

Abstract

A subcutaneous implant for supplying one or more trace elements to an animal is made from a zinc oxide based glass which is prepared in rod form, a short section of the rod being implanted under the skin of an animal. Typically the glass may contain selenium dioxide for supplying small quantities of selenium to the animal.

Description

SPECIFICATION Glass implant This invention relates to glass composition and in particular to water soluble glasses for the supply of trace elements to animals.
One of the problems involved in the husbandry of domesticated animals, e.g. cattle and sheep, is the provision of an adequate supply of trace elements. For example it has been found that, for the healthy growth of such animals, it is necessary that they ingest between 1 and 5 parts per million of selenium based on body weight. In some pastures such a level of selenium occurs naturally but in other areas, e.g. in areas of high rainfall, the natural selenium level is insufficient and must therefore be supplemented either in the form of medication or as an additive to the animal foodstuff. In practice however, because the required quantities of trace elements are so small, it is difficult to achieve the required dosage rate. Furthermore at levels above the required dose trace elements are in general dangerous poisons.
The object of the invention is to minimise or to overcome this disadvantage.
According to the invention there is provided a subcutaneous implant for an animal and adapted to supply one or more trace elements into the bloodstream of the animal, the implant comprising a body of a glass material at least the major proportion which includes one or more oxides of said one or more trace elements together with zince oxide.
A glass employed as a subcutaneous implant for an animal must be non-toxic, nonirritant and must dissolve at a suitable rate so as to supply an adequate level of one or more trace elements into the body fluids of an animal in which the glass is emplanted. We have found that glasses based on zince oxide, which acts as a glass modifying oxide, may be used for this purpose.
The term "glass modifying oxide" is understood to mean an oxide which, whilst it does not of itself form a glass, is capable of forming glass compositions in conjunction with others, generally oxide, glass forming materials. In the glass compositions described herein the trace element or elements may be present in the form of glass forming oxides or as additives together with one or more biologically inert or active glass forming oxides. The components of the glass composition are fused and thoroughly mixed and the melt is then cast e.g. into a rod. A portion of such a glass rod may then be inserted beneath the skin of an animal where the glass constituents slowly dissolve into the animals bloodstream.
In particular, glass compositions suitable for supplying controlled quantities of selenium e.g. to an animal, may be prepared from selenium dioxide (SeO2) and zinc oxide (ZnO) as the major constituents together with oxides of other metals or non metals as minor constituents. These latter minor constituents may be employed to determine the water solubility, and hence the selenium release rate of the glass composition. The technique of solubility adjustment is more fully described in our published specification No. 1,512,637 (C F Drake 49). It has been found in general that the upper limit for the molecular percentage of selenium dioxide in such glass composition is 60 mol % above which the glass composition devitrifies. Also, at selenium concentrations below 40 mol % the glass is hygroscopic and thus unsuitable for controlled selenium release.Small quantities of metal oxides, e.g. alkali metal oxides, may be incorporated in the glass composition to adjust the softening point, ensure freedom from devitrification, and to control the rate of solution.
Thus, for example for glasses of the molar composition xM2O : (50-x) ZnO : 50 SeO2 where M2O is an alkali metal oxide or a mixture of alkali metal oxides, those glasses wherein X < 5 are affectively insoluble whilst those wherein X > 1 8 disintegrate rapidly in water. Therefore, to obtain a useful composition, x should lie within the range 5 to 18.
The glass is prepared by mixing the constituent oxides, i.e. zinc oxide, selenium oxide and optionally other metal and/or non metal oxides, in dry powder form. The mixture is fused into a homogeneous material at a temperature of 500 to 700 for 10 Min. to 1 hr.
in an air atmosphere. Conveniently the glass may be fused in a platinum crucible. The melt may then be cast and cooled. Advantageously the glass composition is formed as a small smooth body, e.g. by drawing into a rod which is then subdivided into short lengths, which may be implanted beneath the skin of an animal so as to release selenium directly into the animal's body fluids.
It will be clear to those skilled in the art that the carbonate, hydroxide nitrate etc. of one or more constituent metals may be used in place of the metal oxide as those components decompose to form the respective oxide during the fusion process.
The following examples illustrate the invention: Example 1 0.67 g anhydrous sodium carbonate, 1.28 g potassium nitrate, 5.6 g selenium dioxide and 4.0 g basic zinc carbonate were fused for 15 Mins. in a platinum crucible at a temperature of 600 C and in an air atmosphere. The total weight loss on fusion was 2.38 g, this loss being attributed to the evolution of CO2, NO2, 2, H20 and some SeO2. The final composition of the clear yellow glass was: Na2O 6.59 mol % K20 6.61 mol % ZnO 36.61 mol % SeO2 50. 19 mol % A 3 mm rod drawn from this melt was immersed in new-born calf serum at a temperature of 38 C and was found to dissolve at a rate of 0.53 mg/day.
Example 2 A glass composition was prepared containing 50.6 mol % selenium dioxide; 38. mol % zinc oxide and 10.8 mol % potassium oxide (K20).
The glass was cast, allowed to cool and was then crushed. A weighed portion of the glass was immersed in new-born calf serum at a temperature of 38to. The dissolution rate of the glass under these conditions was found to be 25 ijg/cm2/hr.

Claims (4)

1. A subcutaneous implant for an animal and adapted to supply one or more trace elements into the bloodstream of the animal, the implant comprising a body of a glass material at least the major proportion of which includes one or oxides of said one or more trace elements together with zinc oxide
2. A subcutaneous implant as claimed in claim 1 and in which said one or more trace elements include selenium.
3. A subcutaneous implant as claimed in claim 1 or 2, and in the form of a rod.
4. A subcutaneous implant for an animal substantially as described herein with reference to the Examples.
4. An animal subcutaneous implant substantially as described herein with reference to the Examples.
CLAIMS (25th Jan 1983)
1. A subcutaneous implant for an animal and adatped to supply one or more trace elements into the bloodstream of the animal, the implant comprising a body of a water soluble glass material at leas the major porportin of which includes one or more oxides of said one or more trace elements together with zinc oxide.
2. A subcutaneous implant as claimed in claim 1 and in which said one or more trace elements include selenium.
3. A subcutaneous implant as claimed in claim 1 or 2, and in the form of a rod.
GB08232140A 1978-09-26 1982-11-10 Subcutaneous implant Expired GB2110086B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08232140A GB2110086B (en) 1978-09-26 1982-11-10 Subcutaneous implant

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7838222A GB2030559B (en) 1978-09-26 1978-09-26 Zinc oxide glass composition
GB08232140A GB2110086B (en) 1978-09-26 1982-11-10 Subcutaneous implant

Publications (2)

Publication Number Publication Date
GB2110086A true GB2110086A (en) 1983-06-15
GB2110086B GB2110086B (en) 1983-10-12

Family

ID=26268978

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08232140A Expired GB2110086B (en) 1978-09-26 1982-11-10 Subcutaneous implant

Country Status (1)

Country Link
GB (1) GB2110086B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2123693A (en) * 1982-07-20 1984-02-08 Nat Res Dev Sustained release device
EP0140538A3 (en) * 1983-09-15 1986-10-08 Stc Plc Controlled release system
US4661339A (en) * 1982-07-20 1987-04-28 National Research Development Corp. Sustained release composition
GB2178422B (en) * 1985-08-02 1990-02-14 Stc Plc Prosthesis formed from water-soluble phosphate glass.

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2123693A (en) * 1982-07-20 1984-02-08 Nat Res Dev Sustained release device
US4661339A (en) * 1982-07-20 1987-04-28 National Research Development Corp. Sustained release composition
EP0140538A3 (en) * 1983-09-15 1986-10-08 Stc Plc Controlled release system
GB2178422B (en) * 1985-08-02 1990-02-14 Stc Plc Prosthesis formed from water-soluble phosphate glass.

Also Published As

Publication number Publication date
GB2110086B (en) 1983-10-12

Similar Documents

Publication Publication Date Title
US4407786A (en) Glass composition
US4283227A (en) ZnO--SeO2 --R2 O soluble glass
KR900006413B1 (en) Water Soluble Glassware
US4350675A (en) Controlled release glass
US4678659A (en) Therapeutic devices incorporating water soluble glass compositions
US5223246A (en) Effervescent composition, its production and use
US4123248A (en) Controlled release fertilizer
GB2081703A (en) Controlled Release Glass
US20080208340A1 (en) Synthetic bone graft
EP0080835B1 (en) Pellets for oral administration to ruminants
GB2164557A (en) Rumen bolus of soluble glass
GB2110086A (en) Subcutaneous implant
GB2077585A (en) Sustained-release bodies of soluble glass tubules
Knott Glasses: agricultural applications
JP3021287B2 (en) Antibacterial agent for sandbox
GB2163346A (en) Water soluble glass rumen boluses for administration to ruminant animals
GB2124899A (en) Improved rumen bolus
US20030060404A1 (en) Aqueous glycerol formulations of somatotropin
AU2018101611A4 (en) Ethephon Formulation
EP0090368B1 (en) Anthelmintic preparations
JPS63307807A (en) Disinfectants in cement making solutions
WO1998029131A9 (en) Aqueous glycerol formulations of somatotropin
AU596629B2 (en) Selenium formulations for pasture/soil application
RU1783970C (en) Method of keeping form animals
CA2281288A1 (en) Method for reducing deflagration of azinphos-methyl

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee